RxDoctor Payments DataLook up a doctor →

Laurie Montano, MD

Internal Medicine · Anchorage, AKNPI 1710958061

Payments from drug & device makers

$6,004in general payments, 2019–2025

Across 332 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$644
  • GSK$606
  • Johnson & Johnson$546
  • Novartis$506
  • Amgen$466
  • Pfizer$454
  • plus $3K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)37$644
GSK38$606
Johnson & Johnson(2 entities)25$546
Novartis33$506
Amgen(2 entities)31$466
Pfizer24$454
AstraZeneca(2 entities)18$338
E.r. Squibb & Sons, L.L.C.13$315
Lilly USA, LLC18$302
Astellas Pharma US Inc9$201
Merck9$143
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$118
UCB, Inc.5$88
Eisai Inc.6$85
Regeneron Healthcare Solutions, Inc.5$76
Sanofi-aventis U.S. LLC5$74
Boehringer Ingelheim4$68
Mallinckrodt Enterprises LLC3$66
Daiichi Sankyo Inc.3$64
Genentech USA, Inc.3$60
Novo Nordisk3$52
Philips North America LLC2$50
Exact Sciences2$47
QOL Medical, LLC3$44
Aurinia Pharma U.S., Inc.2$43
Xeris Pharmaceuticals, Inc.2$40
Sandoz2$37
Bristol Myers Squibb2$37
Teva Pharmaceuticals USA, Inc.2$37
Janssen Scientific Affairs, LLC1$36
Sobi, Inc1$30
Vanda Pharmaceuticals Inc.1$30
Actelion Pharmaceuticals US, Inc.1$29
Kowa Pharmaceuticals America, Inc.1$27
Kyowa Kirin, Inc.1$26
ANI Pharmaceuticals, Inc.1$25
Lundbeck LLC1$25
Amarin Pharma, Inc.1$24
Radius Health, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$20
Biohaven Pharmaceutical Holding Company Ltd.1$20
Sanofi1$19
Mallinckrodt Hospital Products Inc.1$18
Nestle Healthcare Nutrition Inc.1$18
Ironwood Pharmaceuticals, Inc1$15
Neurocrine Biosciences, Inc.1$15

How this compares

$6,004 in reported general payments places this provider in the 95th percentile of 124 internal medicine providers in Alaska.

See all internal medicine providers in Alaska →

Medicare billing

Part B allowed, 2024
$1,008,292
Medicare patients
220
Services billed
16,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Anchorage

See the full list for Alaska →

Where these figures come from

Is this you, or does something look wrong? →